Clinical Trials in Carrboro, North Carolina
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
Angelman Syndrome
Ionis Pharmaceuticals, Inc.158 enrolled38 locationsNCT06914609
Recruiting
Not Applicable
STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade
Autism Spectrum Disorder
Children's Hospital Medical Center, Cincinnati192 enrolled2 locationsNCT06552286
Recruiting
Not Applicable
Health Education Approach to Lung Screening
Lung Cancer
Virginia Commonwealth University675 enrolled3 locationsNCT06070870
Recruiting
Not Applicable
Regulating Together in Tuberous Sclerosis Complex
Behavioral SymptomsTSC
Children's Hospital Medical Center, Cincinnati105 enrolled2 locationsNCT06105736
Recruiting
Phase 1Phase 2
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
Angelman Syndrome
Ionis Pharmaceuticals, Inc.70 enrolled11 locationsNCT05127226
Recruiting
Not Applicable
Resources for Optimizing Outcomes in Toddlers on the Spectrum
Autism Spectrum Disorder
University of North Carolina, Chapel Hill60 enrolled1 locationNCT07086781
Recruiting
Angelman Syndrome Natural History Study
Angelman Syndrome
Boston Children's Hospital300 enrolled11 locationsNCT04507997